If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Health Outcomes
Download FREE Excerpt
9 Info Graphics
13 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Health Outcomes is becoming an integral part of the biopharmaceutical lexicon. Organizations understand that payers and consumers want products that provide positive outcomes for patients' health. One of the key issues facing companies as they establish and expand their Health Outcomes organizations is how to structure and staff these important groups.
To highlight current approaches around Health Outcomes group structure and staffing, Best Practices, LLC conducted a primary research project to inform leaders involved in Health Outcomes operations at biopharmaceutical companies.
This study provides Health Outcomes insights such as:
Twenty-three survey responses from Medical Affairs leaders at 23 top life-science companies. Segments were created for all companies, company size and Health Outcomes maturity level. Additional deep-dive interviews were conducted with five selected Medical Affairs executives.
Biotech; Pharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care; Biopharmaceutical; Clinical Research; Laboratories
Amgen; Roche; AstraZeneca; Bayer; Eli Lilly; Merck; Sanofi; Boehringer Ingelheim; Astellas; Baxter Healthcare; Eisai; Upsher-Smith; Insys Therapeutics; Onyx Pharmaceuticals; Lundbeck; Incyte; Jazz Pharmaceuticals; Merz Pharma; UCB Pharma; ProStrakan; Purdue Pharma; MannKind Corporation; Axon Pharma